Breast cancer: The role of hormone therapy

Seminars in Reproductive Medicine

Volumn 23, Issue 2, 2005, Pages 167-171

  Creasman, William T ^a,b  

^a University Midlife Women's Health   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Anthropomorphic factors; Breast cancer; Estrogen; Exercise; Progestin

Indexed keywords

ESTROGEN; GESTAGEN; PLACEBO;

AGE DISTRIBUTION; ANTHROPOMETRIC PARAMETERS; BREAST CANCER; CANCER RISK; CLINICAL OBSERVATION; CLINICAL TRIAL; ESTROGEN THERAPY; EXERCISE; FEMALE; HAZARD ASSESSMENT; HORMONAL THERAPY; HUMAN; MENOPAUSE; RETROSPECTIVE STUDY; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME;

AGED; BREAST NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; MIDDLE AGED; PROGESTINS; RANDOMIZED CONTROLLED TRIALS;

EID: 18044389099     PISSN: 15268004     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-869484     Document Type: Review

References (14)

1. Lippman ME, Bolan G. Estrogen-responsive human breast cancer in long term cultures. Nature 1975;256:592-593
2. Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995;332:1589-1593
3. Bush TL, Whiteman M, Flaws JA. Hormone replacement therapy and breast cancer: a qualitative review. Obstet Gynecol 2001;98:498-508
4. Creasman WT. Estrogen and cancer. Gynecol Oncol 2002;86:1-9
5. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350:1047-1059
6. Santen RJ, Petroni GR. Relative versus attributable risk of breast cancer from estrogen replacement therapy. J Clin Endocrinol Metab 1999;84:1875-1881
7. WHI. Risks and benefits of estrogen and progestin in healthy postmenopausal women. JAMA 2002;288:321-333
8. Chelbowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative randomized trial. JAMA 2003;289:3243-3253
9. McTierman A, Kooperberg C, White E, et al. Women's Health Initiative Cohort Study. Recreational physical activity and the risk of breast cancer in postmenopausal women. JAMA 2003;290:1331-1336
10. Morimoto LM, White E, Chem Z, et al. Obesity, body size, and risk of postmenopausal breast cancer. The Women's Health Initiative. Cancer Causes Control 2002;13:741-751
11. Million Women Study Collaborators. Breast cancer and hormone replacement therapy in the Million Women Study. Lancet 2003;362:419-427
12. WHI. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA 2004;291:1701-1712
13. Mauvias-Jarvis P, Kultenn F, Compel A. Antiestrogen action of progesterone in breast tissue. Breast Cancer Res Treat 1986;8:179-187
14. Weiss LK, Burkman RT, Cushing-Haugen KL, et al. Hormone replacement therapy regimens and breast cancer risk. Obstet Gynecol 2002;100:1148-1158